1. Home
  2. HRMY vs NFE Comparison

HRMY vs NFE Comparison

Compare HRMY & NFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$37.50

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Logo New Fortress Energy Inc.

NFE

New Fortress Energy Inc.

HOLD

Current Price

$1.22

Market Cap

324.4M

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRMY
NFE
Founded
2017
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil/Gas Transmission
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
324.4M
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
HRMY
NFE
Price
$37.50
$1.22
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
5
Target Price
$51.33
$7.70
AVG Volume (30 Days)
679.6K
9.3M
Earning Date
02-24-2026
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
50.44
N/A
EPS
3.17
N/A
Revenue
$825,944,000.00
$1,768,624,000.00
Revenue This Year
$23.11
N/A
Revenue Next Year
$16.15
$27.93
P/E Ratio
$11.60
N/A
Revenue Growth
21.13
N/A
52 Week Low
$25.52
$0.98
52 Week High
$40.93
$16.66

Technical Indicators

Market Signals
Indicator
HRMY
NFE
Relative Strength Index (RSI) 52.88 50.87
Support Level $35.42 $1.04
Resistance Level $37.79 $1.30
Average True Range (ATR) 1.04 0.09
MACD -0.40 0.01
Stochastic Oscillator 49.76 58.33

Price Performance

Historical Comparison
HRMY
NFE

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About NFE New Fortress Energy Inc.

New Fortress Energy Inc is an integrated gas-to-power company. Its business model spans the entire production and delivery chain from natural gas procurement and liquefaction to logistics, shipping, terminals, and conversion or development of a natural gas-fired generation. It has invested in floating, liquefied natural gas vessels to lower the cost of acquiring gas while securing a long-term supply for its terminals. Its segments include Terminals & Infrastructure, and Ships. It generates the majority of its revenue from the Terminals & Infrastructure segment.

Share on Social Networks: